Photosonix Medical

About:

Photosonix Medical develops CLENS, an energy-based therapy which combines light and ultrasound to treat chronic bacterial infections.

Website: http://www.photosonixmed.com

Top Investors: Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners, Princeton Biopharma Capital Partners

Description:

Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists and primary care physicians. Photosonix Medical is based in Ambler, Pennsylvania.

Total Funding Amount:

$1.77M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ambler, Pennsylvania, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)photosonixmed.com

Founders:

Mark Schafer, Tessie McNeely

Number of Employees:

1-10

Last Funding Date:

2017-01-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai